General Atlantic, established in 1980, is a global growth equity firm headquartered in New York, with additional offices across North America, Europe, Asia, and Latin America. The firm specializes in making large minority investments in growth-stage companies, focusing on sectors such as technology, consumer, financial services, and healthcare. General Atlantic employs a collaborative approach, combining sector-specific expertise, a long-term investment horizon, and a deep understanding of growth drivers to partner with exceptional management teams and build market-leading businesses worldwide.
Park Avenue Plaza, 55 East 52nd Street, 33rd Floor, New York, NY 10055, USA
Connor Antisdale
Principal, GA Credit
Max August
Senior Associate
Kara Barnett
Managing Director
Alexa Bartlett
Principal
Anish Batlaw
Operating Partner
Achim Berg
Operating Partner
Adam Berg
Operating Partner
Michael J. Bevan
Managing Director
Sharad Bhojnagarwala
Principal
Izkandar Bloy
Vice President
Matthew Bonanno
Managing Director, GA Credit
Wilson Bowen
Managing Director
David Buckley
Managing Director and Head of Growth Acceleration Group
Whitney Cacase
Vice President, Human Capital
Jessie Cai
Vice President
Gabriel Caillaux
Co-President, Managing Director, Head of Climate, Head of Business EMEA and Member of the Executive, Investment and Portfolio Committees
Frederico Carvalho
Operating Partner
Henri de Castries
Chairman, Europe
Rodrigo Catunda
Managing Director and Co-Head of Brazil Office
Chris Caulkin
Managing Director and Head of Technology for EMEA
Thomas Cefalu
Analyst
Luis Cervantes
Managing Director and Head of Mexico Office
Zeev Thepris Charaf
Vice President
Laura Chen
Vice President
Betty Chen
Senior Associate, BeyondNetZero Team
Andrew Crawford
Managing Director, Chairman of the Portfolio Committee and Global Head of Consumer
Alex Crisses
Managing Director, Global Head of New Investment Sourcing and Co-Head of Emerging Growth
Jason Currier
Vice President - FINANCE
Steven Denning
Chairman
Harrison DiGia
Vice President
Matthew Dorr
Principal
Mike Drittel
Vice President
Jonathan Durham
Managing Director and Global Head of Technology Buyouts
Mark F. Dzialga
Managing Director
Martin Escobari
Co-President, Managing Director and Head of Global Growth Equity
Oscar Fan
Managing Director and Head of Consumer for China
Andrew Ferrer
Managing Director
Christian Figge
Managing Director
Natasha Fowlie
Principal
Stas Futoransky
Principal, GA Credit
Roger Gao
Managing Director
Sofia Freyria
Vice President
Jon Gol
Principal, GA Credit
Michael Gosk
Managing Director, CFO
William Grabe
Managing Director
Fletcher Gregory
Principal
Sascha Guenther
Managing Director
Nadia Hadi
Vice President
Rhea Hamilton
Managing Director
Asher Hecht
Principal
Robert Hedlund
Managing Director of CA Credit
David Hodgson
Vice Chairman and Member of the Investment Team
Ingrid van der Hoorn
Vice President, Finance
Tom Hussey
Principal
Jeffrey Kaczmarski
Senior Associate
Melis Kahya
Managing Director and Head of Consumer for EMEA
Justin Kotzin
Managing Director - Head of Capital Markets
Mia Krishnamurthy
Analyst
John LaDien
Principal
Peter Lafer
Principal
Emmanuel Lagarrigue
Managing Director, BeyondNetZero
Samuel Lerer
Vice President
Anton Levy
Co-President, Managing Director, Member of the Investment Committee and Chairman of Global Technology Group
Tony Li
Principal
Victor Li
Managing Director
Hilary Lindemann
Principal
Simon Liu
Principal
Alok C. Misra
Operating Partner and COO India
Sandeep Naik
Managing Director, Member of the Management Committee and Head of Business, India and Southeast Asia
Joern Nikolay
Managing Director and Head of DACH
Raph Osnoss
Managing Director
Raphael Osnoss
Managing Director
Christian Osterland
Principal
Seckin Ozdamar
Principal, Growth Acceleration Group
Armaan Pai
Vice President
Andy Papadakos
Executive Vice President
Annie Paydar
Managing Director, Member of the Executive Committee and Global Head of Human Capital
Jason Pitts
Vice President
Nate Powell
Managing Director, GA Credit
Jordan Principe
Principal, GA Credit
Shantanu Rastogi
Managing Director and Head of India
Jon Michael Reese
Vice President
Kell Reilly
Managing Director
Gary Reiner
Operating Partner
Maria Ribeiro
Vice President
Luiz Ribeiro
Managing Director
Graham Robertson
Principal
Pierre Samec
Operating Partner
Ben Sherman
Principal
Paul Stamas
Managing Director and Global Head of Financial Services
Lefei Sun
Managing Director
Justin Sunshine
Managing Director
David Swift
Managing Director, Head of Climate and Sustainability Strategies
Tanzeen M. Syed
Managing Director
Varun Talukdar
Principal
Victor Taslim
Vice President
Philipp Thun-Hohenstein
Principal
Graves Tompkins
Managing Director and COO
John Toriello
Managing Director and Global Head of Portfolio Management and Due Diligence
Ben Tour
Vice President
Vinay Trivedi
Principal and Investment Team
Javier Valenzuela
Senior Associate
Robbert Vorhoff
Managing Director and Global Head of Healthcare
Matthew Wachter
Associate
Joanne Wang
Associate
Ke Wei
Managing Director
Caroline Woodworth
Principal
Leo Wouters
Managing Director, Private Credit Strategy, GA Credit
Eric Zhang
Managing Director and Head of China
Christopher Apfel
Vice President
Ziyad Baeshen
Vice President
Anthony Costa
Vice President
Past deals in Pennsylvania
Immunocore
Post in 2022
Immunocore Limited is a biotechnology company based in Abingdon, United Kingdom, with a focus on discovering and developing novel therapeutics for cancer, viral diseases, and autoimmune conditions. The company specializes in T cell receptor (TCR) technology, which allows it to create innovative bispecific immunotherapies. Its lead product candidate, IMCgp100, is currently undergoing clinical trials for the treatment of metastatic melanoma. Immunocore's proprietary platform enables efficient manufacturing of TCR-based drugs, addressing significant unmet medical needs. Founded in 1999 and previously known as Avidex Limited, Immunocore has expanded its operations with an additional office in Conshohocken.
Duolingo
Series H in 2020
Duolingo, Inc. is a language-learning platform founded in 2011 and headquartered in Pittsburgh, Pennsylvania. The company offers a wide array of educational resources, including 98 courses across nearly 40 languages, accessible for free or through a premium subscription model. With around 30 million active users, Duolingo has become a leading educational app globally, known for its engaging and gamified learning experience. Its offerings include the Duolingo Language Learning App, Super Duolingo, and the Duolingo English Test, which provides AI-driven language assessments. Additionally, Duolingo for Schools enables teachers to monitor their students' progress. The company's technology leverages advanced data analytics and artificial intelligence to enhance the learning process, while its revenue is primarily generated through subscriptions, in-app purchases, and business services.
Duolingo
Series G in 2020
Duolingo, Inc. is a language-learning platform founded in 2011 and headquartered in Pittsburgh, Pennsylvania. The company offers a wide array of educational resources, including 98 courses across nearly 40 languages, accessible for free or through a premium subscription model. With around 30 million active users, Duolingo has become a leading educational app globally, known for its engaging and gamified learning experience. Its offerings include the Duolingo Language Learning App, Super Duolingo, and the Duolingo English Test, which provides AI-driven language assessments. Additionally, Duolingo for Schools enables teachers to monitor their students' progress. The company's technology leverages advanced data analytics and artificial intelligence to enhance the learning process, while its revenue is primarily generated through subscriptions, in-app purchases, and business services.
Immunocore
Series B in 2020
Immunocore Limited is a biotechnology company based in Abingdon, United Kingdom, with a focus on discovering and developing novel therapeutics for cancer, viral diseases, and autoimmune conditions. The company specializes in T cell receptor (TCR) technology, which allows it to create innovative bispecific immunotherapies. Its lead product candidate, IMCgp100, is currently undergoing clinical trials for the treatment of metastatic melanoma. Immunocore's proprietary platform enables efficient manufacturing of TCR-based drugs, addressing significant unmet medical needs. Founded in 1999 and previously known as Avidex Limited, Immunocore has expanded its operations with an additional office in Conshohocken.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.